Medroxyprogesterone Acetate Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Medroxyprogesterone Acetate Tablet (tablet) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on Aug 31, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Pfizer Inc.
- Package NDC
- 0009-0051-01
- Dosage Form
- Tablet
- Presentation
- PROVERA, Tablet, 10 mg (NDC 0009-0051-01)
- Initial Posting
- Aug 31, 2026